Immunosuppression with cyclophosphamide in the dog.
C W Putnam, C. G. Halgrimson, Carl G. Groth, Noboru Kashiwagi, K. A. Porter, TE Starzl
Abstract
C W Putnam, C. G. Halgrimson, Carl G. Groth, Noboru Kashiwagi, K. A. Porter, TE Starzl
Abstract
Cyclophosphamide significantly diminished the canine humoral antibody response to sheep red blood cells and tended to prevent arterial lesions in renal homografts. However, cyclophosphamide failed to prolong renal homograft survival when administered to dogs as the sole immunosuppressive agent, and it did not add to the effectiveness of azathioprine when given as a supplement to the azathioprine and administered simultaneously or sequentially.
OpenAlex reports 14 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Cyclophosphamide significantly diminished the canine humoral antibody response to sheep red blood cells and tended to prevent arterial lesions in renal homografts. However, cyclophosphamide failed to prolong renal homograft survival when administered to dogs as the sole immunosuppressive agent, and it did not add to the effectiveness of azathioprine when given as a supplement to the azathioprine and administered simultaneously or sequentially.
Key concepts: Azathioprine, Cyclophosphamide, Immunosuppression, Immunology, Medicine, Antibody, Chemotherapy, Internal medicine